Drug delivery systems .2. Camptothecin 20-O-poly(ethylene glycol)ester transport forms

被引:95
作者
Greenwald, RB
Pendri, A
Conover, C
Gilbert, C
Yang, R
Xia, J
机构
[1] Enzon Inc., Piscataway, NJ 08854-3969
关键词
D O I
10.1021/jm9600555
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:1938 / 1940
页数:3
相关论文
共 13 条
[1]  
BUNDGAARD H, 1986, BIOREVERSIBLE DERIVA, P49
[2]   THE STRUCTURAL BASIS OF CAMPTOTHECIN INTERACTIONS WITH HUMAN SERUM-ALBUMIN - IMPACT ON DRUG STABILITY [J].
BURKE, TG ;
MI, ZH .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (01) :40-46
[3]  
Garzon-Aburbeh A., 1990, [No title captured], Patent No. 4943579
[4]   Drug delivery systems: Water soluble taxol 2'-poly(ethylene glycol) ester prodrugs - Design and in vivo effectiveness [J].
Greenwald, RB ;
Gilbert, CW ;
Pendri, A ;
Conover, CD ;
Xia, J ;
Martinez, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :424-431
[5]   MODIFICATION OF THE HYDROXY LACTONE RING OF CAMPTOTHECIN - INHIBITION OF MAMMALIAN TOPOISOMERASE-I AND BIOLOGICAL-ACTIVITY [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HOLDEN, KG ;
JAKAS, DR ;
GALLAGHER, G ;
MATTERN, MR ;
MONG, SM ;
BARTUS, JO ;
JOHNSON, RK ;
KINGSBURY, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (03) :715-720
[6]  
JAXEL C, 1989, CANCER RES, V49, P1465
[7]   SYNTHESIS AND ANTITUMOR-ACTIVITY OF NOVEL WATER-SOLUBLE DERIVATIVES OF CAMPTOTHECIN AS SPECIFIC INHIBITORS OF TOPOISOMERASE-I [J].
LUZZIO, MJ ;
BESTERMAN, JM ;
EMERSON, DL ;
EVANS, MG ;
LACKEY, K ;
LEITNER, PL ;
MCINTYRE, G ;
MORTON, B ;
MYERS, PL ;
PEEL, M ;
SISCO, JM ;
STERNBACH, DD ;
TONG, WQ ;
TRUESDALE, A ;
UEHLING, DE ;
VUONG, A ;
YATES, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (03) :395-401
[8]   DIFFERENTIAL INTERACTIONS OF CAMPTOTHECIN LACTONE AND CARBOXYLATE FORMS WITH HUMAN BLOOD COMPONENTS [J].
MI, ZH ;
BURKE, TG .
BIOCHEMISTRY, 1994, 33 (34) :10325-10336
[9]   MARKED INTERSPECIES VARIATIONS CONCERNING THE INTERACTIONS OF CAMPTOTHECIN WITH SERUM ALBUMINS - A FREQUENCY-DOMAIN FLUORESCENCE SPECTROSCOPIC STUDY [J].
MI, ZH ;
BURKE, TG .
BIOCHEMISTRY, 1994, 33 (42) :12540-12545
[10]  
POTMESIL M, 1994, CANCER RES, V54, P1431